240 related articles for article (PubMed ID: 12696001)
1. Highly conserved Neisseria meningitidis inner-core lipopolysaccharide epitope confers protection against experimental meningococcal bacteremia.
Plested JS; Harris SL; Wright JC; Coull PA; Makepeace K; Gidney MA; Brisson JR; Richards JC; Granoff DM; Moxon ER
J Infect Dis; 2003 Apr; 187(8):1223-34. PubMed ID: 12696001
[TBL] [Abstract][Full Text] [Related]
2. Functional activity of anti-Neisserial surface protein A monoclonal antibodies against strains of Neisseria meningitidis serogroup B.
Moe GR; Zuno-Mitchell P; Lee SS; Lucas AH; Granoff DM
Infect Immun; 2001 Jun; 69(6):3762-71. PubMed ID: 11349041
[TBL] [Abstract][Full Text] [Related]
3. Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits.
Cox AD; Zou W; Gidney MA; Lacelle S; Plested JS; Makepeace K; Wright JC; Coull PA; Moxon ER; Richards JC
Vaccine; 2005 Oct; 23(43):5045-54. PubMed ID: 16046037
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide heterogeneity and escape mechanisms of Neisseria meningitidis: possible consequences for vaccine development.
Rune Andersen S; Kolberg J; Høiby EA; Namork E; Caugant DA; Oddvar Frøholm L; Jantzen E; Bjune G
Microb Pathog; 1997 Sep; 23(3):139-55. PubMed ID: 9281472
[TBL] [Abstract][Full Text] [Related]
5. Functional opsonic activity of human serum antibodies to inner core lipopolysaccharide (galE) of serogroup B meningococci measured by flow cytometry.
Plested JS; Ferry BL; Coull PA; Makepeace K; Lehmann AK; MacKinnon FG; Griffiths HG; Herbert MA; Richards JC; Moxon ER
Infect Immun; 2001 May; 69(5):3203-13. PubMed ID: 11292742
[TBL] [Abstract][Full Text] [Related]
6. Murine monoclonal antibodies to PorA of Neisseria meningitidis show reduced protective activity in vivo against B:15:P1.7,16 subtype variants in an infant rat infection model.
Toropainen M; Saarinen L; van der Ley P; Kuipers B; Käyhty H
Microb Pathog; 2001 Mar; 30(3):139-48. PubMed ID: 11273739
[TBL] [Abstract][Full Text] [Related]
7. Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity.
Welsch JA; Moe GR; Rossi R; Adu-Bobie J; Rappuoli R; Granoff DM
J Infect Dis; 2003 Dec; 188(11):1730-40. PubMed ID: 14639545
[TBL] [Abstract][Full Text] [Related]
8. Immunization with meningococcal outer-membrane protein vesicles containing lipooligosaccharide protects mice against lethal experimental group B Neisseria meningitidis infection and septic shock.
Quakyi EK; Frasch CE; Buller N; Tsai CM
J Infect Dis; 1999 Sep; 180(3):747-54. PubMed ID: 10438363
[TBL] [Abstract][Full Text] [Related]
9. Conservation and accessibility of an inner core lipopolysaccharide epitope of Neisseria meningitidis.
Plested JS; Makepeace K; Jennings MP; Gidney MA; Lacelle S; Brisson J; Cox AD; Martin A; Bird AG; Tang CM; Mackinnon FM; Richards JC; Moxon ER
Infect Immun; 1999 Oct; 67(10):5417-26. PubMed ID: 10496924
[TBL] [Abstract][Full Text] [Related]
10. Enzyme linked immunosorbent assay (ELISA) for the detection of serum antibodies to the inner core lipopolysaccharide of Neisseria meningitidis group B.
Plested JS; Gidney MA; Coull PA; Griffiths HG; Herbert MA; Bird AG; Richards JC; Moxon ER
J Immunol Methods; 2000 Apr; 237(1-2):73-84. PubMed ID: 10725453
[TBL] [Abstract][Full Text] [Related]
11. Outer membrane vesicles (OMVs) and detoxified lipooligosaccharide (dLOS) obtained from Brazilian prevalent N. meningitidis serogroup B strains protect mice against homologous and heterologous meningococcal infection and septic shock.
Jessouroun E; da Silveira IF; Larangeira AP; Pereira S; Fernandes SA; Rabinovitch L; Frasch CE; Castro-Faria-Neto HC; Bozza PT
Vaccine; 2004 Jun; 22(20):2617-25. PubMed ID: 15193387
[TBL] [Abstract][Full Text] [Related]
12. Short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis of potential value for production of outer membrane vesicle vaccines.
Andersen SR; Bjune G; Lyngby J; Bryn K; Jantzen E
Microb Pathog; 1995 Sep; 19(3):159-68. PubMed ID: 8559044
[TBL] [Abstract][Full Text] [Related]
13. Assessment of vaccine potential of the Neisseria-specific protein NMB0938.
Sardiñas G; Climent Y; Rodríguez Y; González S; García D; Cobas K; Caballero E; Pérez Y; Brookes C; Taylor S; Gorringe A; Delgado M; Pajón R; Yero D
Vaccine; 2009 Nov; 27(49):6910-7. PubMed ID: 19751688
[TBL] [Abstract][Full Text] [Related]
14. Immunization of mice with Neisseria meningitidis serogroup B genomic expression libraries elicits functional antibodies and reduces the level of bacteremia in an infant rat infection model.
Yero CD; Pajón FR; Caballero ME; Cobas AK; López HY; Fariñas MM; Gonzáles BS; Acosta DA
Vaccine; 2005 Jan; 23(7):932-9. PubMed ID: 15603895
[TBL] [Abstract][Full Text] [Related]
15. Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures.
Jäkel A; Plested JS; Hoe JC; Makepeace K; Gidney MA; Lacelle S; St Michael F; Cox AD; Richards JC; Moxon ER
Vaccine; 2008 Dec; 26(51):6655-63. PubMed ID: 18835574
[TBL] [Abstract][Full Text] [Related]
16. Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine.
Welsch JA; Rossi R; Comanducci M; Granoff DM
J Immunol; 2004 May; 172(9):5606-15. PubMed ID: 15100304
[TBL] [Abstract][Full Text] [Related]
17. Identification by genomic immunization of a pool of DNA vaccine candidates that confer protective immunity in mice against Neisseria meningitidis serogroup B.
Yero D; Pajón R; Pérez Y; Fariñas M; Cobas K; Diaz D; Solis RL; Acosta A; Brookes C; Taylor S; Gorringe A
Vaccine; 2007 Jul; 25(28):5175-88. PubMed ID: 17544180
[TBL] [Abstract][Full Text] [Related]
18. Development, characterization, and functional activity of a panel of specific monoclonal antibodies to inner core lipopolysaccharide epitopes in Neisseria meningitidis.
Gidney MA; Plested JS; Lacelle S; Coull PA; Wright JC; Makepeace K; Brisson JR; Cox AD; Moxon ER; Richards JC
Infect Immun; 2004 Jan; 72(1):559-69. PubMed ID: 14688137
[TBL] [Abstract][Full Text] [Related]
19. Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection.
Martin D; Cadieux N; Hamel J; Brodeur BR
J Exp Med; 1997 Apr; 185(7):1173-83. PubMed ID: 9104804
[TBL] [Abstract][Full Text] [Related]
20. Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup B.
Pillai S; Howell A; Alexander K; Bentley BE; Jiang HQ; Ambrose K; Zhu D; Zlotnick G
Vaccine; 2005 Mar; 23(17-18):2206-9. PubMed ID: 15755596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
